SILVERSTEIN JONATHAN

Resignation (see Remarks) at LIFECELL CORP · on record since Mar 17, 2004
Director at AVANIR PHARMACEUTICALS · on record since Feb 15, 2006
Director at INSULET CORP · on record since May 18, 2007
Director at NxStage Medical, Inc. · on record since Jul 24, 2008
10% owner at NxStage Medical, Inc. · on record since Jul 24, 2008
Director at Relypsa Inc · on record since Nov 20, 2013
10% owner at Relypsa Inc · on record since Nov 20, 2013
Director at INTERCEPT PHARMACEUTICALS, INC. · on record since Nov 20, 2012
10% owner at INTERCEPT PHARMACEUTICALS, INC. · on record since Nov 20, 2012
Director at Roka BioScience, Inc. · on record since Jul 24, 2014
10% owner at Roka BioScience, Inc. · on record since Jul 24, 2014
Director at GLAUKOS Corp · on record since Jun 30, 2015
10% owner at GLAUKOS Corp · on record since Jun 30, 2015
Director at Audentes Therapeutics, Inc. · on record since Jul 25, 2016
10% owner at Audentes Therapeutics, Inc. · on record since Jul 25, 2016
Director at scPharmaceuticals Inc. · on record since Nov 21, 2017
Director at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 4, 2017
Director at Adicet Bio, Inc. · on record since Jan 30, 2018
10% owner at · on record since Jan 30, 2018
Director at · on record since Feb 19, 2019
10% owner at · on record since Feb 19, 2019
Director at · on record since Jan 30, 2020
10% owner at · on record since Jan 30, 2020

Insider trading activity of SILVERSTEIN JONATHAN

Transactions on record: 254; since Mar 21, 2005

Open-market buys: 12; $51.3M

Open-market sells: 113; $309.7M

Companies traded: 12; last filing Oct 6, 2020

Figures computed from official regulatory filings — .

Companies where SILVERSTEIN JONATHAN has traded

11 tx · $21.9M · Oct 6, 2020
7 tx · $8M · Jun 5, 2020
11 tx · Nov 25, 2019
65 tx · $104.6M · Mar 6, 2018
2 tx · Nov 21, 2017
24 tx · $4.6M · Sep 23, 2016
10 tx · $500K · Aug 25, 2016
91 tx · $231.3M · Nov 27, 2015
19 tx · $8.4M · Nov 20, 2013
3 tx · May 28, 2010
2 tx · May 18, 2007
9 tx · $9.6M · Mar 5, 2007

Track record of SILVERSTEIN JONATHAN

Statistical track record

Free

Open-market buys: 17

Last buy: Oct 2, 2020

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of SILVERSTEIN JONATHAN

Co-insiders of SILVERSTEIN JONATHAN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Arcutis Biotherapeutics, Inc.	Oct 6, 2020	Buy	200,000	25.00 USD	$5M	SEC
Arcutis Biotherapeutics, Inc.	Oct 6, 2020	Buy	296,000	25.00 USD	$7.4M	SEC
Adicet Bio, Inc.	Jun 5, 2020	AwardD (derivative)	14,414	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Mar 3, 2020	AwardD (derivative)	24,000	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Buy	382,388	17.00 USD	$6.5M	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-429,786	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	859,573	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-859,573	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	2,825,603	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	429,786	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Buy	176,500	17.00 USD	$3M	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-2,825,603	0.00 USD	—	SEC
AVEDRO INC	Nov 25, 2019	OtherD (derivative)	-8,314	—	—	SEC
AVEDRO INC	Nov 25, 2019	OtherD (derivative)	-3,005	—	—	SEC
AVEDRO INC	Nov 25, 2019	Other	-4,240,128	—	—	SEC
AVEDRO INC	Jun 18, 2019	AwardD (derivative)	3,005	0.00 USD	—	SEC
Adicet Bio, Inc.	May 9, 2019	AwardD (derivative)	14,414	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	Other	3,370,786	—	—	SEC
AVEDRO INC	Feb 19, 2019	Other	383,746	—	—	SEC
AVEDRO INC	Feb 19, 2019	AwardD (derivative)	8,314	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-3,370,786	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-383,746	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	Other	333,178	—	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-333,178	0.00 USD	—	SEC
GLAUKOS Corp	Mar 6, 2018	Sell	-46,676	32.06 USD	$1.5M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Arcutis Biotherapeutics, Inc.	Oct 6, 2020	Buy	200,000	25.00 USD	$5M	SEC
Arcutis Biotherapeutics, Inc.	Oct 6, 2020	Buy	296,000	25.00 USD	$7.4M	SEC
Adicet Bio, Inc.	Jun 5, 2020	AwardD (derivative)	14,414	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Mar 3, 2020	AwardD (derivative)	24,000	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Buy	382,388	17.00 USD	$6.5M	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-429,786	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	859,573	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-859,573	0.00 USD	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	2,825,603	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Other	429,786	—	—	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	Buy	176,500	17.00 USD	$3M	SEC
Arcutis Biotherapeutics, Inc.	Feb 4, 2020	OtherD (derivative)	-2,825,603	0.00 USD	—	SEC
AVEDRO INC	Nov 25, 2019	OtherD (derivative)	-8,314	—	—	SEC
AVEDRO INC	Nov 25, 2019	OtherD (derivative)	-3,005	—	—	SEC
AVEDRO INC	Nov 25, 2019	Other	-4,240,128	—	—	SEC
AVEDRO INC	Jun 18, 2019	AwardD (derivative)	3,005	0.00 USD	—	SEC
Adicet Bio, Inc.	May 9, 2019	AwardD (derivative)	14,414	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	Other	3,370,786	—	—	SEC
AVEDRO INC	Feb 19, 2019	Other	383,746	—	—	SEC
AVEDRO INC	Feb 19, 2019	AwardD (derivative)	8,314	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-3,370,786	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-383,746	0.00 USD	—	SEC
AVEDRO INC	Feb 19, 2019	Other	333,178	—	—	SEC
AVEDRO INC	Feb 19, 2019	OtherD (derivative)	-333,178	0.00 USD	—	SEC
GLAUKOS Corp	Mar 6, 2018	Sell	-46,676	32.06 USD	$1.5M	SEC